SynthesisActa odontologica Scandinavica2026
Incidence of sinus membrane perforation in transcrestal graftless maxillary sinus augmentation: a meta-analysis.
Synthesis in Acta odontologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis meta-analysis aimed to evaluate Schneiderian membrane perforation incidence and complications in graftless transcrestal sinus floor elevation. MATERIALS AND
methodsSeveral databases (PubMed, Embase, Cochrane Library, Web of Science and Scopus) were searched for studies reporting perforation rates, early implant failure (≤12 months) and postoperative complications. Two reviewers independently selected studies, extracted data and assessed bias. Random-effects meta-analysis was performed. Evidence certainty was graded using the GRADE system.
resultsAmong 14 studies comprising 2119 sinus-lift sites, the pooled incidence of Schneiderian membrane perforation was 1% (95% CI: 0% (95% CI: 0% the pooled incidence of Schneiderian membrane perforation was 1% (95% CI: 0% months) and postoperative failure (≤12 months) was also 1% (95% CI: 0-6%) based on 711 evaluated implants, showing no heterogeneity (I² = 0%). No postoperative complications (acute sinusitis or epistaxis) were reported in the included literature. Subgroup analysis revealed that motor-driven techniques were associated with a significantly higher perforation rate (34%) compared to conventional osteotome methods (0%). The certainty of evidence was rated as very low for all outcomes, including membrane perforation and secondary indicators.
conclusionsGraftless transcrestal sinus elevation is associated with low Schneiderian membrane perforation rates, favourable implant survival and minimal postoperative complications. Despite methodological heterogeneity, current evidence supports the clinical safety of graftless techniques. CLINICAL RELEVANCE: Clinicians can confidently utilise graftless sinus floor elevation approaches with appropriate patient selection and careful surgical techniques to minimise complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.